- Home
- CBFV vs ADAP Comparison
CBFV vs ADAP Comparison
Compare CBFV & ADAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBFV
- ADAP
- Stock Information
- Founded
- CBFV 1901
- ADAP 2008
- Country
- CBFV United States
- ADAP United Kingdom
- Employees
- CBFV N/A
- ADAP N/A
- Industry
- CBFV Major Banks
- ADAP Biotechnology: Pharmaceutical Preparations
- Sector
- CBFV Finance
- ADAP Health Care
- Exchange
- CBFV Nasdaq
- ADAP Nasdaq
- Market Cap
- CBFV 148.0M
- ADAP 158.6M
- IPO Year
- CBFV N/A
- ADAP 2015
- Fundamental
- Price
- CBFV $28.28
- ADAP $0.58
- Analyst Decision
- CBFV Hold
- ADAP Strong Buy
- Analyst Count
- CBFV 2
- ADAP 4
- Target Price
- CBFV $26.00
- ADAP $2.79
- AVG Volume (30 Days)
- CBFV 7.9K
- ADAP 2.3M
- Earning Date
- CBFV 01-29-2025
- ADAP 03-05-2025
- Dividend Yield
- CBFV 3.54%
- ADAP N/A
- EPS Growth
- CBFV 62.63
- ADAP N/A
- EPS
- CBFV 4.36
- ADAP N/A
- Revenue
- CBFV $67,214,000.00
- ADAP $175,041,000.00
- Revenue This Year
- CBFV N/A
- ADAP $204.91
- Revenue Next Year
- CBFV $0.21
- ADAP N/A
- P/E Ratio
- CBFV $6.48
- ADAP N/A
- Revenue Growth
- CBFV 24.04
- ADAP 146.27
- 52 Week Low
- CBFV $20.75
- ADAP $0.53
- 52 Week High
- CBFV $33.72
- ADAP $2.05
- Technical
- Relative Strength Index (RSI)
- CBFV 44.20
- ADAP 41.87
- Support Level
- CBFV $26.53
- ADAP $0.55
- Resistance Level
- CBFV $28.65
- ADAP $0.65
- Average True Range (ATR)
- CBFV 0.50
- ADAP 0.05
- MACD
- CBFV 0.04
- ADAP 0.00
- Stochastic Oscillator
- CBFV 71.14
- ADAP 31.31
About CBFV CB Financial Services Inc.
CB Financial Services Inc operates as a bank holding company. The company conducts its operations through its wholly-owned subsidiary, Community Bank, a Pennsylvania-chartered commercial bank. The Bank offers products and services related to residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a range of deposit products for individuals and businesses in its market area. It operates in two operating units namely Community Banking and Insurance brokerage service segment. The bank generates its revenue in the form of interest.
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.